Advertisement
Screener

ORAGENICS, INC. (OGEN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ORAGENICS, INC. Cash Flow Breakdown

Cash flow breakdown shows where ORAGENICS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $9.25M went out.
  • Fiscal year ended 2025-12-31: from financing, $16.78M came in.
  • Fiscal year ended 2025-12-31: change in cash, $7.53M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew debtCommercial paperStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$9.25M$2.20M$2.63M$11.95M*$7.53M
2024-12-31-$8.60M$6.67M-$693.11K*-$2.62M
2023-12-31-$7.29M-$936.28K-$7.94M
2022-12-31-$15.23M-$115.52K-$15.84M
2021-12-31-$13.47M-$43.88K$26.68M-$3.54M*$9.63M
2020-12-31-$16.95M$11.34M$4.99M*-$628.42K
2019-12-31-$13.01M-$25.21K$11.10M*-$1.94M
2018-12-31-$9.08M-$124.73K-$200.75K$13.80M$9.65M*$14.04M
2017-12-31-$6.36M-$157.95K$8.61M*$2.09M
2016-12-31-$7.08M$1.68M-$158.10K$2.64M$1.97M*-$948.58K
2015-12-31-$5.19M-$101.23K-$159.95K-$5.45M
2014-12-31-$5.56M-$110.25K-$158.21K-$5.83M
2013-12-31-$6.76M-$18.81K-$631.74K$13.80M$6.35M
2012-12-31-$5.21M-$11.10K-$140.03K-$224.32K$13.00M$2.34M*$9.75M
2011-12-31-$5.49M-$3.75K-$172.55K$5.71M*$39.64K
2010-12-31-$6.45M-$88.08K-$107.31K$1.50M$4.97M*-$169.49K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtCommercial paperStaff share taxNew shares soldNot split outChange in cash
2026-06-30-$2.19M*$0.00*$0.00*
2026-03-31-$2.20M$4.00M$79.21K$1.71M
2025-12-31-$2.84M*$0.00*-$1.14K*
2025-09-30-$2.98M*$0.00*$0.00*$12.41M*
2025-06-30-$1.31M*$0.00*$0.00*
2025-03-31-$2.11M$2.20M$2.64M$2.56M
2024-12-31-$2.02M*$1.97K*
2024-09-30-$1.97M*$3.88M*
2024-06-30-$1.54M*$948.00K*
2024-03-31-$3.06M$1.84M-$1.41M
2023-12-31-$1.10M*-$1000.00K*
2023-09-30-$1.50M*$732.12K*
2023-06-30-$2.58M*
2023-03-31-$2.11M-$2.27M
2022-12-31-$2.43M*-$3.44K*
2022-09-30-$3.78M*-$37.03K*
2022-06-30-$3.38M*$0.00*
2022-03-31-$5.64M-$75.05K-$5.89M
2021-12-31-$2.48M*-$19.75K*$0.00*
2021-09-30-$4.58M*$0.00*
2021-06-30-$2.08M*$0.00*
2021-03-31-$4.33M$26.68M-$3.49M*$18.86M
2020-12-31-$3.63M*$11.23M*
2020-09-30-$4.67M*$5.08M*
2020-06-30-$4.83M*
2020-03-31-$3.82M-$3.90M
2019-12-31-$3.94M*-$13.86K*
2019-09-30-$3.38M*$0.00*-$3.43M*
2019-06-30-$3.49M*-$65.00K*-$3.63M*
2019-03-31-$2.21M$11.35M*$9.14M
2018-12-31-$2.98M*-$64.48K*-$66.19K*$9.51M*$6.40M*
2018-09-30-$2.45M*-$46.08K*$12.43M*$9.87M*
2018-06-30-$2.28M*-$46.85K*$1.51M*-$817.33K*
2018-03-31-$1.37M-$41.63K-$1.41M
2017-12-31-$1.36M*-$47.59K*$4.65M*$3.24M*
2017-09-30-$1.34M*-$34.55K*$2.21M*$834.53K*
2017-06-30-$1.77M*-$40.29K*$1.72M*-$86.25K*
2017-03-31-$1.90M-$35.51K-$1.91M
2016-12-31-$1.96M*$0.00*-$45.33K*$1.00*$984.77K*-$1.02M*
2016-09-30-$1.57M*$425.02K*-$34.80K*$0.00*$984.67K*-$196.30K*
2016-06-30-$1.92M*-$44.02K*$2.64M*$1.93M*
2016-03-31-$1.62M-$33.95K-$1.65M
2015-12-31-$1.66M*$0.00*-$46.16K*-$1.71M*
2015-09-30-$1.34M*-$7.34K*-$34.32K*-$1.38M*
2015-06-30-$943.69K*-$21.65K*-$44.62K*-$966.12K*
2015-03-31-$1.29M-$72.24K-$34.84K-$1.40M
2014-12-31-$1.18M*-$90.54K*-$44.72K*-$1.32M*
2014-09-30-$1.10M*-$1.24K*-$34.52K*-$1.13M*
2014-06-30-$1.70M*$424.00*-$44.55K*-$1.74M*
2014-03-31-$1.58M-$18.89K-$34.42K-$1.64M
2013-12-31-$1.22M*-$1.16K*$9.87M*-$636.09K*$8.01M*
2013-09-30-$1.96M*-$11.28K*$3.91M*$1.90M*
2013-06-30-$2.00M*-$31.97K*-$1.98M*
2013-03-31-$1.58M-$30.73K-$1.58M
2012-12-31-$1.74M*-$40.52K*-$97.03K*$1.09M*-$1.83M*
2012-09-30-$1.18M*-$31.68K*$11.84M*$10.63M*
2012-06-30-$1.15M*-$36.28K*$1.35M*$162.54K*
2012-03-31-$1.14M$1.22M*$720.86K*$796.21K
2011-12-31-$1.39M*-$51.22K*$1.61M*$171.74K*
2011-09-30-$1.52M*-$39.07K*$1.56M*$0.00*
2011-06-30-$1.46M*-$43.34K*$1.45M*-$56.43K*
2011-03-31-$1.12M-$38.92K$1.09M*-$75.67K
2010-12-31-$1.77M*$91.30K*-$14.77K*$0.00*$1.32M*-$373.11K*
2010-09-30-$1.40M*-$173.18K*-$37.27K*$1.00M*$894.17K*$288.46K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02